Literature DB >> 18261952

Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes.

Crispian Scully1, Jose V Bagan.   

Abstract

This paper provides a synopsis of the main papers on imaging, treatment and treatment outcomes in patients with oral and oropharyngeal squamous cell carcinoma (OSCC) and head and neck SCC (HNSCC) published in 2007 in Oral Oncology - an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, and all other scientific articles relating to the aetiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck, and orofacial disease in patients with malignant disease.

Entities:  

Mesh:

Year:  2008        PMID: 18261952     DOI: 10.1016/j.oraloncology.2008.01.006

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

1.  Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.

Authors:  Gunjan Srivastava; Ajay Matta; Guodong Fu; Raj Thani Somasundaram; Alessandro Datti; Paul G Walfish; Ranju Ralhan
Journal:  Mol Oncol       Date:  2015-05-21       Impact factor: 6.603

Review 2.  Tumor microenvironment - Unknown niche with powerful therapeutic potential.

Authors:  Tomasz Kolenda; Weronika Przybyła; Marta Kapałczyńska; Anna Teresiak; Maria Zajączkowska; Renata Bliźniak; Katarzyna M Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17

3.  MAGE-A antigens in patients with primary oral squamous cell carcinoma.

Authors:  Urs D A Müller-Richter; Albert Dowejko; Silvia Peters; Stephan Rauthe; Tobias Reuther; Stefan Gattenlöhner; Torsten E Reichert; Oliver Driemel; Alexander C Kübler
Journal:  Clin Oral Investig       Date:  2009-06-02       Impact factor: 3.573

4.  Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma.

Authors:  Qian Jiang; Sdek Patima; Dong-Xia Ye; Hong-Ya Pan; Pin Zhang; Zhi-Yuan Zhang
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

5.  Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy.

Authors:  Gunjan Srivastava; Raj Thani Somasundaram; Paul G Walfish; Ranju Ralhan
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma.

Authors:  Kai-Chun Li; Kuo-Tai Hua; Yi-Shen Lin; Chia-Yi Su; Jenq-Yuh Ko; Michael Hsiao; Min-Liang Kuo; Ching-Ting Tan
Journal:  Mol Cancer       Date:  2014-07-15       Impact factor: 27.401

7.  Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer.

Authors:  Takashi Naohara; Hiromichi Aono; Tsunehiro Maehara; Hideyuki Hirazawa; Shinya Matsutomo; Yuji Watanabe
Journal:  J Funct Biomater       Date:  2013-02-18

8.  The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer.

Authors:  Cong Peng; Xiaoting Jia; Yan Xiong; Jiang Yin; Nan Li; Yingen Deng; Kai Luo; Qiong Zhang; Chengkun Wang; Zhijie Zhang; Guopei Zheng; Zhimin He
Journal:  Oncotarget       Date:  2015-08-21

Review 9.  Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.

Authors:  Ajay Matta; Ranju Ralhan
Journal:  Head Neck Oncol       Date:  2009-03-02

Review 10.  Clinical application of genetics to guide prevention and treatment of oral diseases.

Authors:  K S Kornman; P J Polverini
Journal:  Clin Genet       Date:  2014-05-10       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.